INS and obesity disorder: Insulin normally suppresses hepatic gluconeogenic enzyme expression and stimulates muscle glucose uptake (Figure 1), and both actions are impaired in diet‐induced obesity, the metabolic syndrome, type 2 diabetes (DIO/MetS/T2DM).